High-Performance liquid chromatographic assay for the simultaneous determination of tramadol and its metabolites in microsomal fractions of human liver
- 1 November 1996
- journal article
- Published by Elsevier in Journal of Chromatography B: Biomedical Sciences and Applications
- Vol. 686 (2) , 221-227
- https://doi.org/10.1016/s0378-4347(96)00236-8
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Bioactivation of the narcotic drug codeine in human liver is mediated by the polymorphic monooxygenase catalyzing debrisoquine 4-hydroxylation (cytochrome P-450 dbl/bufI)Published by Elsevier ,2005
- Variations in Drug Metabolism Due to Genetic PolymorphismClinical Drug Investigation, 1993
- Recent Developments in Hepatic Drug OxidationClinical Pharmacokinetics, 1990
- Morphine formation from codeine in rat brain: A possible mechanism of codeine analgesiaLife Sciences, 1990
- Codeine O‐demethylation co‐segregates with polymorphic debrisoquine hydroxylation.British Journal of Clinical Pharmacology, 1989
- POLYMORPHIC O-DEMETHYLATION OF CODEINEThe Lancet, 1988
- Determination of tramadol in human serum by capillary gas chromatography with nitrogen-selective detectionJournal of Chromatography B: Biomedical Sciences and Applications, 1986
- Characterization of a common genetic defect of cytochrome P-450 function (debrisoquine-sparteine type polymorphism) — Increased michaelis constant (km) and loss of stereoselectivity of bufuralol 1′-hydroxylation in poor metabolizersBiochemical and Biophysical Research Communications, 1984
- Defective N-oxidation of sparteine in man: A new pharmacogenetic defectEuropean Journal of Clinical Pharmacology, 1979
- POLYMORPHIC HYDROXYLATION OF DEBRISOQUINE IN MANThe Lancet, 1977